Medication Assisted Treatment (MAT)

Discussions Archivos Imágenes Videos Enlaces Eventos Knowledge Share Todo(s)

Fuente:https://sin-adiccion.blogspot.com/2026/09/brenipatide-brenipatida.html

Dado el estado actual de la evidencia, la brenipatida no debe sustituir a los tratamientos aprobados o recomendados por las guías clínicas para los trastornos por consumo de alcohol, opioides o tabaco fuera del contexto de un ensayo clínico.

References / Referencias

Cai, M., Choi, T., Xie, Y., & Al-Aly, Z. (2026). Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: Cohort study. BMJ, 392, e086886. https://doi.org/10.1136/bmj-2025-086886 [pubmed...

Source: Spadaro, A., Kelly, T., Morris, J., & Heeney, M. E. (2026). Emergency Departments Need to Train and Hire More Sub-Specialists in Addiction Medicine. AEM Education and Training, 10(3), e70184. https://doi.org/10.1002/aet2.70184 According to the 2024 National Survey on Drug Use and Health, 48...

Emergency Departments Need to Train and Hire More Sub‐Specialists in Addiction Medicine.pdf

Source: Baird, A., White, S. A., Das, R., Tatum, N., & Bisgaard, E. K. (2024). Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal. Communications Medicine, 4, 114. https://doi.org/10.1038/s43856-024-00536-5 Abstract Background Opioid use in...

Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal.pdf

Source: Irvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., & Green, T. C. (2022). Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: A modelling study. The Lancet...

Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics a modelling study.pdf

Source: Carpenter, J., Murray, B. P., Atti, S., Moran, T. P., Yancey, A., & Morgan, B. (2020). Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl. Journal of Medical Toxicology, 16(1), 41-48. https://doi.org/10.1007/s13181-019-00735-w Abstract Introduction Illicitly...

Click here → to read the full text

Source: Kleinman RA, Larney S, Sule NO, Ma C, Hauck TS, Kurdyak P. Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors. JAMA Netw Open. 2026;9(8):e2629313. doi:10.1001/jamanetworkopen.2026.29313 Key Points Question Among individuals with a past-year opioid overdose starting opioid...

Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors.pdf

Source: Hayes, C. J., Raciborski, R. A., Acharya, M., Noor, N. B., Nunes, E. V., & Winhusen, T. J. (2026). Evaluating the optimal duration of medication treatment for opioid use disorder. Addiction, 121(4), 922-933. https://doi.org/10.1111/add.70211 Abstract Background and aims Clinicians have...

Addiction - 2026 - Hayes - Evaluating the optimal duration of medication treatment for opioid use disorder_1.pdf

Source: Okunogbe A, Peltz A, Danovitch I, Ober AJ, Nuckols TK. Cost-Effectiveness of the START Hospital Addiction Consultation Service for Opioid Use Disorder Treatment. JAMA Netw Open. 2026;9(5):e2611324. doi:10.1001/jamanetworkopen.2026.11324 Key Points Question Is a hospital-based addiction...

Cost-Effectiveness of the START Hospital Addiction Consultation Service for Opioid Use Disorder Treatment_0.pdf

Source: Saloner, B., O’Rourke, A., Ruelas-Vargas, K., Song, M., Ramsey, K. S., & Bandara, S. (2026). Driving Distance From US Jails to Opioid Treatment Programs. JAMA Network Open, 9(3), e264044-e264044. Discussion In this study, 51.5% of US jails were located more than a 30-minute drive from an OTP...

Driving Distance From US Jails to Opioid Treatment Programs_0.pdf

Source: Engeriser, J.L., Hutch, T., Smith, C.L. et al. Buprenorphine initiation from fentanyl using low-dose intramuscular ketamine: a pilot study. Addict Sci Clin Pract 21, 23 (2026). https://doi.org/10.1186/s13722-026-00649-3 Abstract Background Buprenorphine is an effective medication for...

Buprenorphine initiation from fentanyl using low-dose intramuscular ketamine a pilot study.pdf

Source: DeLisle, D. E., Mark, T. L., Katz, C., Dowd, W. N., Barch, D., & Kluckman, M. (2026). Opioid Treatment Programs’ Medicaid Patient Retention Rates. JAMA Network Open, 9(1), e2553538. Key Points Question What are the Medicaid patient retention rates in opioid treatment programs (OTPs) in the...

Opioid Treatment Programs’ Medicaid Patient Retention Rates.pdf

Source: Howell BA, Kim J, Thornhill TA, et al. Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit. JAMA Netw Open. 2026;9(2):e2557361. doi:10.1001/jamanetworkopen.2025.57361 Key Points Question How does transportation access to methadone treatment for opioid use disorder via...

Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit.pdf

Source: Hunt, T., Oser, C., Friedmann, P. et al. Overdose education and naloxone distribution in jails: Examining the impact of the Communities That HEAL intervention in 4 states. Health Justice 13, 47 (2025). https://doi.org/10.1186/s40352-025-00353-5 Abstract Background Opioid-related overdose is...

Overdose education and naloxone distribution in jails Examining the impact of the Communities That HEAL intervention in 4 states.pdf

Source: Carrieri PM, Michel L, Lions C, Cohen J, Vray M, Mora M, et al. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9(11): e112328. https://doi.org/10.1371/journal.pone.0112328 Abstract Objective Methadone coverage is...

Methadone Induction in Primary Care for Opioid Dependence A Pragmatic Randomized Trial ANRS Methaville.pdf

Source: Knudsen, H.K., Freeman, P.R., Oyler, D.R. et al. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model. Addict Sci Clin Pract 18, 72 (2023). https://doi.org/10.1186/s13722-023-00426-6 Abstract Background...

Scaling up overdose education and naloxone distribution in Kentucky adoption and reach achieved through a hub with many spokes model.pdf

Upcoming Events

There aren't any upcoming events

All Events

Brenipatida para los trastornos por uso de sustancias: resumen de la evidencia actual (Septiembre 2026)

Emergency Departments Need to Train and Hire More Sub-Specialists in Addiction Medicine

Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal

Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study

Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl

Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors

Evaluating the optimal duration of medication treatment for opioid use disorder

Cost-Effectiveness of the START Hospital Addiction Consultation Service for Opioid Use Disorder Treatment

Driving Distance From US Jails to Opioid Treatment Programs

Buprenorphine initiation from fentanyl using low-dose intramuscular ketamine: a pilot study

Opioid Treatment Programs’ Medicaid Patient Retention Rates

Travel Time to Methadone Treatment Via Personal Vehicle vs Public Transit

Overdose education and naloxone distribution in jails: Examining the impact of the Communities That HEAL intervention in 4 states

Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville)

Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model

Upcoming Events